Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

4.190 +1.200 (+40.13%)
Streaming Delayed Price Updated: 12:10 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,668,661
Open 3.205
Bid (Size) 4.180 (10)
Ask (Size) 4.190 (6)
Prev. Close 2.990
Today's Range 3.130 - 4.650
52wk Range 0.9700 - 5.070
Shares Outstanding 62,064,270
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44.... 
Via Benzinga
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
+78.3%
+78.3%
1 Month
+107.4%
+107.4%
3 Month
+299.0%
+299.0%
6 Month
+224.8%
+224.8%
1 Year
+3.2%
+3.2%

More News

Read More
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference
From Zura Bio Limited
Via Business Wire
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
From Zura Bio Limited
Via Business Wire
Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well
Via Stocktwits
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Zura Bio
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Zura Bio Announces Chief Financial Officer Transition
From Zura Bio Limited
Via Business Wire
Zura Bio to Present at the Jefferies Global Healthcare Conference
From Zura Bio Limited
Via Business Wire
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa
From Zura Bio Limited
Via Business Wire
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates
From Zura Bio Limited
Via Business Wire
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates
From Zura Bio Limited
Via Business Wire
Zura Bio to Present at the Leerink Partners Global Healthcare Conference
From Zura Bio Limited
Via Business Wire
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis
From Zura Bio Limited
Via Business Wire
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference
From Zura Bio Limited
Via Business Wire
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
From Zura Bio Limited
Via Business Wire
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
From Zura Bio Limited
Via Business Wire
Zura Bio to Participate in Two Upcoming Investor Conferences in November
From Zura Bio
Via Business Wire
Zura Bio to Present at Three Upcoming Investor Conferences in September
From Zura Bio Limited
Via Business Wire
ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
Via InvestorPlace
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
From Zura Bio Limited
Via Business Wire
Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants
From Zura Bio Limited
Via Business Wire

Frequently Asked Questions

Is Zura Bio Limited - Class A Ordinary shares publicly traded?
Yes, Zura Bio Limited - Class A Ordinary shares is publicly traded.
What exchange does Zura Bio Limited - Class A Ordinary shares trade on?
Zura Bio Limited - Class A Ordinary shares trades on the Nasdaq Stock Market
What is the ticker symbol for Zura Bio Limited - Class A Ordinary shares?
The ticker symbol for Zura Bio Limited - Class A Ordinary shares is ZURA on the Nasdaq Stock Market
What is the current price of Zura Bio Limited - Class A Ordinary shares?
The current price of Zura Bio Limited - Class A Ordinary shares is 4.190
When was Zura Bio Limited - Class A Ordinary shares last traded?
The last trade of Zura Bio Limited - Class A Ordinary shares was at 09/30/25 12:10 PM ET
What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?
The market capitalization of Zura Bio Limited - Class A Ordinary shares is 260.05M
How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?
Zura Bio Limited - Class A Ordinary shares has 260M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.